Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Not If, But When: The Yom Kippur Terror Attack in Belleville 
A Canary’s Song: What Antisemitism Reveals About the Health of Canadian Democracy 
Elbows Up With Europe Too: Why Canada’s Pivot to the EU Raises the Same Digital Sovereignty Questions as the U.S. 
A Century After Keeping Jewish Students Out, Universities Are Letting Them Be Pushed Out 
The Lessons of 9/11 We Forgot After October 7th
